"Our study demonstrated that the drug CT-179, used in combination with standard radiation therapy can cross the blood brain ...

Scientists at The Hospital for Sick Children (SickKids) have discovered a way to stop tumor growth before it starts for a subtype of medulloblastoma, the most common childhood malignant brain cancer.

SickKids researchers have identified OLIG2, a protein that activates stem cells driving medulloblastoma, the most common childhood brain cancer. Blocking this protein with CT-179 prevented tumor ...